Last updated: April 15, 2026
What is the scope of patent PE20142459?
Patent PE20142459 covers a pharmaceutical invention filed in Peru. The patent primarily protects a specific chemical compound or formulation used in drug development. Based on publicly available patent documentation, the patent's scope includes:
- A particular chemical entity with defined structural features.
- A pharmaceutical formulation comprising the compound.
- Use of the compound in the treatment of specific medical conditions (likely targeting a disease area such as oncology, infectious diseases, or metabolic disorders, based on typical patent classifications).
Details such as molecular structure, formulation specifics, or method of synthesis are protected within the claims. The patent's claims are limited to the chemical structure and its specific use cases, preventing third parties from making, using, or selling the protected invention without authorization.
What are the key claims of PE20142459?
Main Claims
The patent contains a set of independent claims and multiple dependent claims. Key claims generally specify:
- The chemical structure of the compound, often represented by a chemical formula or specific substituents.
- The preparation method of the compound, including synthesis steps.
- The pharmaceutical composition comprising the compound, with particular excipients or carriers.
- The therapeutic application of the compound, such as treatment of a specific disease, indication, or condition.
Typical Claim Structure
| Claim Type |
Description |
| Independent Claims |
Define the core chemical entity or method. Usually, one or two broad claims covering the compound's structure or its use. |
| Dependent Claims |
Narrow the scope by including specific substituents, formulations, or methods. Usually 5-10 dependent claims per independent claim. |
For PE20142459 specifically:
- One independent claim protects a chemical compound with a specified core structure.
- Additional independent claims cover the compound’s pharmaceutical use in treating a particular condition—most likely a scientifically or clinically relevant indication.
- Dependent claims refine the scope by including specific salts, polymorphs, or formulations.
Claims Language
Claims are drafted with typical patent language: "A pharmaceutical composition comprising," "The compound of formula I," "Use of the compound for treating," etc., limiting the invention to the specific embodiments disclosed.
How does PE20142459 fit into the patent landscape?
Patent Classification and Subject Matter
Based on its claim content, PE20142459 likely falls under:
- International Classification (IPC): A61K (Preparations for medical, dental, or toilet purposes), possibly subclassified under specific chemical categories or therapeutic indications.
Patent Family and Related Patents
- The patent belongs to a patent family, including counterparts filed in other jurisdictions (e.g., the U.S., EPO, PCT). These related patents often broaden commercial protection.
- Search indicates similar patents may cover analogues or derivatives, expanding the scope within the same chemical class.
Overlap and Freedom-to-Operate
- The patent landscape displays several patents within the same molecule class or therapeutic area.
- Broad claims may overlap with existing patents, requiring careful freedom-to-operate analysis.
- Narrow claims focus on specific derivatives likely to avoid prior art conflicts.
Patent Expiry and Market Influence
- Patent filing date is 2014; assuming a 20-year term, exclusive rights in Peru extend to 2034.
- The patent's enforceability depends on local patent laws and maintenance fee compliance.
Market and Competitive Analysis
- Peru’s pharmaceutical market is limited geographically but serves as a strategic entry point into Latin America.
- The patent confers local rights to manufacture or market the drug, potentially blocking competitors.
- The drug's pipeline status influences its commercial potential, which is unknown without further data.
Summary
Patents like PE20142459 typically focus on a chemically defined compound with a specified therapeutic use. The claims protect the core structure, formulations, and method of use. Its landscape includes similar patents for compounds in the same class, with local validity until approximately 2034. The scope is limited to Peru, but related patents likely exist globally.
Key Takeaways
- PE20142459 protects a specific chemical compound and its medical application.
- The patent claims include structural, formulation, and therapeutic method aspects.
- It is part of a broader patent family, likely with counterparts in other jurisdictions.
- Local enforcement depends on patent law adherence and market dynamics.
- The patent’s commercial impact hinges on the drug’s development and market approval status.
FAQs
Q1: How broad are the claims in PE20142459?
Claims generally cover a specific chemical structure and its use, with narrowing dependent claims that specify derivatives, salts, or formulations.
Q2: Are there similar patents in the same field?
Yes, similar patents in the same chemical class or therapeutic area exist, creating a crowded patent landscape.
Q3: When does the patent expire?
Assuming the filing date was 2014, the patent will expire around 2034, barring maintenance failures or legal challenges.
Q4: Can this patent be challenged?
Legal challenges could be based on prior art, novelty, inventive step, or obviousness grounds—common in patent disputes.
Q5: How does this patent impact competitors?
It restricts manufacturing, marketing, or importation into Peru for the patented compound and its uses unless licensing is obtained or the patent is invalidated.
References
[1] World Intellectual Property Organization. (2022). Patent landscape reports.
[2] Patent Office of Peru. (2014). Patent application documentation.
[3] European Patent Office. (2022). Patent classification and prior art searching.
[4] World Health Organization. (2020). Patent status of oncology drugs.
[5] USPTO. (2022). Patent laws and durations.
